Chronic myelogenous leukemia in accelerated phase

被引：0
作者：
Huang, Q [1 ]
机构：
[1] City Hope Natl Med Ctr, Div Pathol, Duarte, CA 91010 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2005年 / 129卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：710 / 710
页数：1
相关论文
共 50 条
  • [41] Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase
    Vora, A
    Bhutani, M
    Sharma, A
    Raina, V
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1833 - 1834
  • [42] Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia: Accelerated phase: A rare case with review of literature (vol 56, pg 303, 2013)
    Kumar, Narender
    Ahluwalia, Jasmina
    Malhotra, Pankaj
    Sachdeva, Man Updesh Singh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2014, 57 (01) : 162 - 163
  • [43] Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase
    Schelker, Roland Christian
    Huber, Elisabeth
    Herr, Wolfgang
    Vogelhuber, Martin
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 219 - 222
  • [44] Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase
    Jiang, Qian
    Xu, Lan-Ping
    Liu, Dai-Hong
    Liu, Kai-Yan
    Chen, Shan-Shan
    Jiang, Bin
    Jiang, Hao
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Zhang, Xiao-Hui
    Wang, Yu
    Qin, Ya-Zhen
    Liu, Yan-Rong
    Lai, Yue-Yun
    Huang, Xiao-Jun
    BLOOD, 2011, 117 (11) : 3032 - 3040
  • [45] Combination therapy with interferon Alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemia
    Bourantas, KL
    Syrou, M
    Tsiara, S
    Danella, M
    Konstantinides, P
    ACTA HAEMATOLOGICA, 1996, 95 (02) : 117 - 121
  • [46] Abnormal B Lymphoid Blasts May Not Always Indicate Accelerated or Blast Phase in Chronic Myelogenous Leukemia (CML)
    Soma, Lori
    Ding, Cheng
    Cherian, Sindhu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (05) : 700 - 700
  • [47] Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase
    Schelker, R. C.
    Huber, E.
    Herr, W.
    Vogelhuber, M.
    Oncology Research and Treatment, 2015, 38 : 131 - 131
  • [48] PLATELET-DERIVED GROWTH-FACTOR EXPRESSION IN ACCELERATED AND BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA WITH MYELOFIBROSIS
    KIMURA, A
    NAKATA, Y
    HYODO, H
    KURAMOTO, A
    SATOW, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 303 - 307
  • [49] Chronic myelogenous leukemia
    Hochhaus, A.
    La Rosee, P.
    Eigendorff, E.
    Ernst, T.
    INTERNIST, 2015, 56 (04): : 333 - 343
  • [50] CHRONIC MYELOGENOUS LEUKEMIA
    MOLONEY, WC
    CANCER, 1978, 42 (02) : 865 - 873
12345